- Home
- MAA vs SLRX Comparison
MAA vs SLRX Comparison
Compare MAA & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAA
- SLRX
- Stock Information
- Founded
- MAA 1977
- SLRX N/A
- Country
- MAA United States
- SLRX United States
- Employees
- MAA N/A
- SLRX N/A
- Industry
- MAA Real Estate Investment Trusts
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MAA Real Estate
- SLRX Health Care
- Exchange
- MAA Nasdaq
- SLRX Nasdaq
- Market Cap
- MAA 16.6B
- SLRX 3.6M
- IPO Year
- MAA 1994
- SLRX N/A
- Fundamental
- Price
- MAA $131.47
- SLRX $4.25
- Analyst Decision
- MAA Buy
- SLRX
- Analyst Count
- MAA 19
- SLRX 0
- Target Price
- MAA $161.79
- SLRX N/A
- AVG Volume (30 Days)
- MAA 828.2K
- SLRX 263.5K
- Earning Date
- MAA 10-29-2025
- SLRX 11-13-2025
- Dividend Yield
- MAA 4.61%
- SLRX N/A
- EPS Growth
- MAA 10.39
- SLRX N/A
- EPS
- MAA 4.85
- SLRX N/A
- Revenue
- MAA $2,200,155,000.00
- SLRX N/A
- Revenue This Year
- MAA $1.92
- SLRX N/A
- Revenue Next Year
- MAA $3.09
- SLRX N/A
- P/E Ratio
- MAA $27.08
- SLRX N/A
- Revenue Growth
- MAA 1.19
- SLRX N/A
- 52 Week Low
- MAA $131.17
- SLRX $3.64
- 52 Week High
- MAA $173.38
- SLRX $108.00
- Technical
- Relative Strength Index (RSI)
- MAA 26.84
- SLRX 51.81
- Support Level
- MAA $133.28
- SLRX $3.86
- Resistance Level
- MAA $137.69
- SLRX $4.66
- Average True Range (ATR)
- MAA 1.76
- SLRX 0.37
- MACD
- MAA -0.42
- SLRX -0.08
- Stochastic Oscillator
- MAA 3.44
- SLRX 62.11
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.